← Browse by Condition
Medical Condition
er positive breast cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 2
NCT06382948 Phase 3
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Enrollment
240 pts
Location
Austria, Czechia, Fr...
Sponsor
MedSIR
NCT04886531 Phase 2
Recruiting
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
Enrollment
30 pts
Location
United States
Sponsor
Ruth O'Regan
NCT05720260 Phase 2
Recruiting
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Enrollment
42 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...